C World Wide Group Holding A Aclaris Therapeutics, Inc. Transaction History

C World Wide Group Holding A

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 02, 2019	SELL	$2.13 - $7.06 $316,317 - $1.05 Million	-148,506 Closed	0 $0
Q1 2019 May 03, 2019	SELL	$5.63 - $7.84 $25,042 - $34,872	-4,448 Reduced 2.91%	148,506 $890,000
Q4 2018 Feb 12, 2019	SELL	$6.3 - $15.4 $332,621 - $813,073	-52,797 Reduced 25.66%	152,954 $1.13 Million
Q3 2018 Nov 05, 2018	SELL	$14.38 - $20.89 $524,870 - $762,485	-36,500 Reduced 15.07%	205,751 $2.99 Million
Q2 2018 Aug 03, 2018	BUY	$16.46 - $20.33 $2.75 Million - $3.39 Million	166,986 Added 221.86%	242,251 $4.84 Million
Q1 2018 May 03, 2018	SELL	$17.08 - $25.64 $227,761 - $341,909	-13,335 Reduced 15.05%	75,265 $1.32 Million
Q4 2017 Feb 07, 2018	SELL	$21.47 - $27.8 $165,319 - $214,060	-7,700 Reduced 8.0%	88,600 $2.19 Million
Q3 2017 Nov 06, 2017	BUY	$23.02 - $28.8 $2.22 Million - $2.77 Million	96,300	96,300 $2.49 Million

50.7M

30.6K

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $255M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

Get notified when there are updates to the investment portfolio of C World Wide Group Holding A, based on Form 13F filings with the SEC.

Stay updated on C World Wide Group Holding A with notifications on news.